Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 27, 2016, Pages 7620-7625

  Li, Qisheng ^a   Sodroski, Catherine ^a   Lowey, Brianna ^a   Schweitzer, Cameron J ^a   Cha, Helen ^a   Zhang, Fang ^a   Liang, T Jake ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

E cadherin; Epithelial mesenchymal transition; Hepatitis C virus; Tight junction; Viral entry

Indexed keywords

CD81 ANTIGEN; CLAUDIN 1; ENVELOPE PROTEIN; MESSENGER RNA; MICRORNA 122; NERVE CELL ADHESION MOLECULE; OCCLUDIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIRUS RNA; CADHERIN; CLDN1 PROTEIN, HUMAN; OCLN PROTEIN, HUMAN;

ARTICLE; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA REPLICATION; RNA TRANSLATION; VESICULOVIRUS; VIRUS ENTRY; GENE EXPRESSION REGULATION; HEPACIVIRUS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

CADHERINS; CELL LINE, TUMOR; CLAUDIN-1; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS C; HUMANS; OCCLUDIN; VIRUS INTERNALIZATION;

EID: 84977582738     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1602701113     Document Type: Article

References (52)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST (2013) Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology 57(4):1333-1342.
2. Rosen HR (2011) Clinical practice. Chronic hepatitis C infection. N Engl J Med 364(25): 2429-2438.
3. Verna EC, Brown RS, Jr (2006) Hepatitis C virus and liver transplantation. Clin Liver Dis 10(4):919-940.
4. Liang TJ, Ghany MG (2013) Current and future therapies for hepatitis C virus infection. N Engl J Med 368(20):1907-1917.
5. Chisari FV (2005) Unscrambling hepatitis C virus-host interactions. Nature 436(7053): 930-932.
6. Bartenschlager R, Cosset FL, Lohmann V (2010) Hepatitis C virus replication cycle. J Hepatol 53(3):583-585.
7. Scheel TK, Rice CM (2013) Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat Med 19(7):837-849.
8. Li Q, et al. (2014) Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle. PLoSPathog 10(5): e1004163.
9. Dubuisson J, Cosset FL (2014) Virology and cell biology of the hepatitis C virus life cycle: An update. J Hepatol 61(1, suppl):S3-S13.
10. Pileri P, et al. (1998) Binding of hepatitis C virus to CD81. Science 282(5390):938-941.
11. Scarselli E, et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21(19):5017-5025.
12. Evans MJ, et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446(7137):801-805.
13. Ploss A, et al. (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457(7231):882-886.
14. Lupberger J, et al. (2011) EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17(5):589-595.
15. Sainz B, Jr, et al. (2012) Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18(2):281-285.
16. Martin DN, Uprichard SL (2013) Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proc Natl Acad Sci USA 110(26):10777-10782.
17. Li Q, et al. (2009) A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci USA 106(38):16410-16415.
18. Narbus CM, et al. (2011) HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle. J Virol 85(22):12087-12092.
19. Shi Q, Jiang J, Luo G (2013) Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes. J Virol 87(12):6866-6875.
20. Steinmann E, Brohm C, Kallis S, Bartenschlager R, Pietschmann T (2008) Efficient transencapsidation of hepatitis C virus RNAs into infectious virus-like particles. J Virol 82(14):7034-7046.
21. Masaki T, et al. (2010) Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription. J Virol 84(11):5824-5835.
22. Ploss A, Evans MJ (2012) Hepatitis C virus host cell entry. Curr Opin Virol 2(1):14-19.
23. Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178-196.
24. Wilson GK, et al. (2012) A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration. J Hepatol 56(4):803-809.
25. Lin W, et al. (2010) Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. Gastroenterology 138(7):2509-2518.
26. Harris TJ, Tepass U (2010) Adherens junctions: From molecules to morphogenesis. Nat Rev Mol Cell Biol 11(7):502-514.
27. Bryant DM, Stow JL (2004) The ins and outs of E-cadherin trafficking. Trends Cell Biol 14(8):427-434.
28. Bonazzi M, Cossart P (2011) Impenetrable barriers or entry portals? The role of cellcell adhesion during infection. J Cell Biol 195(3):349-358.
29. Wilkins C, et al. (2013) IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology 57(2):461-469.
30. Reardon SN, et al. (2012) CDH1 is essential for endometrial differentiation, gland development, and adult function in the mouse uterus. Biol Reprod 86(5):141,1-110.
31. Akkari L, et al. (2012) Hepatitis C viral protein NS5A induces EMT and participates in oncogenic transformation of primary hepatocyte precursors. J Hepatol 57(5): 1021-1028.
32. Bose SK, Meyer K, Di Bisceglie AM, Ray RB, Ray R (2012) Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes. J Virol 86(24): 13621-13628.
33. Park J, Jang KL (2014) Hepatitis C virus represses E-cadherin expression via DNA methylation to induce epithelial to mesenchymal transition in human hepatocytes. Biochem Biophys Res Commun 446(2):561-567.
34. Ripoli M, et al. (2011) Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein. Virus Res 160(1-2):74-81.
35. Arora P, Kim EO, Jung JK, Jang KL (2008) Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett 261(2):244-252.
36. Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer 7(6):415-428.
37. Schaller T, et al. (2007) Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 81(9):4591-4603.
38. Tscherne DM, et al. (2007) Superinfection exclusion in cells infected with hepatitis C virus. J Virol 81(8):3693-3703.
39. Shlomai A, de Jong YP, Rice CM (2014) Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol 26:78-88.
40. Yang B, Guo M, Herman JG, Clark DP (2003) Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163(3):1101-1107.
41. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871-890.
42. Mailly L, et al. (2015) Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody. Nat Biotechnol 33(5):549-554.
43. Molina S, et al. (2008) Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol 82(1):569-574.
44. Fofana I, et al. (2013) A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission. PLoS One 8(5): e64221.
45. Meuleman P, et al. (2008) Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo. Hepatology 48(6):1761-1768.
46. Catanese MT, et al. (2007) High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J Virol 81(15):8063-8071.
47. Zhong J, et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102(26):9294-9299.
48. Wakita T, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11(7):791-796.
49. Lindenbach BD, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309(5734):623-626.
50. Gottwein JM, et al. (2009) Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49(2):364-377.
51. Lavillette D, et al. (2005) Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41(2):265-274.
52. Coller KE, et al. (2009) RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog 5(12):e1000702.